Drug delivery system

Nagar , et al. June 28, 2

Patent Grant D760374

U.S. patent number D760,374 [Application Number D/440,941] was granted by the patent office on 2016-06-28 for drug delivery system. This patent grant is currently assigned to INSULINE MEDICAL LTD.. The grantee listed for this patent is Insuline Medical Ltd. Invention is credited to Elisha Amir, Gadi Amit, Gabriel Bitton, Ron Nagar, Barbara A. Stettler, Brandon Warren.


United States Patent D760,374
Nagar ,   et al. June 28, 2016

Drug delivery system

Claims

CLAIM We claim the ornamental design for a drug delivery system, as shown and described.
Inventors: Nagar; Ron (Petach-Tikva, IL), Bitton; Gabriel (Jerusalem, IL), Amir; Elisha (Livnim, IL), Amit; Gadi (San Mateo, CA), Stettler; Barbara A. (Oakland, CA), Warren; Brandon (San Francisco, CA)
Applicant:
Name City State Country Type

Insuline Medical Ltd

Petach-Tikva

N/A

IL
Assignee: INSULINE MEDICAL LTD. (Petach-Tikva, IL)
Appl. No.: D/440,941
Filed: December 28, 2012

Current U.S. Class: D24/108
Current International Class: 2401
Field of Search: ;D24/107,108,111-113,127,128 ;604/67,181,184,187,151,180

References Cited [Referenced By]

U.S. Patent Documents
D423102 April 2000 Mertenat
D554253 October 2007 Kornerup
D564087 March 2008 Yodfat et al.
D576267 September 2008 Mogensen et al.
D602586 October 2009 Foley et al.
7713258 May 2010 Adams et al.
7713262 May 2010 Adams et al.
D619245 July 2010 Moga et al.
D629503 December 2010 Caffey et al.
7927306 April 2011 Cross et al.
7931621 April 2011 Cross et al.
7976493 July 2011 Carter et al.
D672031 December 2012 Hunt et al.
D678998 March 2013 Galbriath et al.
D685083 June 2013 Schneider et al.
D685084 June 2013 Guarraia et al.
D687140 July 2013 Guarraia et al.
D687141 July 2013 Schneider et al.
D687536 August 2013 Guarraia et al.
D688784 August 2013 Schneider et al.
8668675 March 2014 Chase et al.
2004/0044306 March 2004 Lynch et al.
2009/0012472 January 2009 Ahm et al.
2009/0198215 August 2009 Chong et al.
2009/0240240 September 2009 Hines et al.
2009/0254041 October 2009 Krag et al.
2010/0049128 February 2010 McKenzie et al.
2011/0172609 July 2011 Moga et al.
2011/0172637 July 2011 Moga et al.
2011/0172638 July 2011 Moga et al.
2011/0172639 July 2011 Moga et al.
2011/0172645 July 2011 Moga et al.
2014/0107580 April 2014 Momose
Foreign Patent Documents
WO 2012153295 Nov 2012 WO
Primary Examiner: Pratt; Deanna L
Assistant Examiner: Bekic; Lilyana
Attorney, Agent or Firm: Cooley LLP

Description



FIG. 1 is a perspective view of a control unit in a drug delivery system;

FIG. 2 is a side view of the control unit in the drug delivery system;

FIG. 3 is another side view of the control unit in the drug delivery system;

FIG. 4 is a back side view of the control unit in the drug delivery system;

FIG. 5 is a front side view of the control unit in the drug delivery system;

FIG. 6 is a top view of the control unit in the drug delivery system;

FIG. 7 is a bottom view of the control unit in the drug delivery system;

FIG. 8 is a perspective view of the control unit being coupled to an injection window in the drug delivery system;

FIG. 9 is a side view of the control unit being coupled to the injection window in the drug delivery system;

FIG. 10 is another side view of the control unit being coupled to the injection window in the drug delivery system;

FIG. 11 is a front view of the control unit being coupled to the injection window in the drug delivery system;

FIG. 12 is a back view of the control unit being coupled to the injection window in the drug delivery system;

FIG. 13 is a top view of the control unit being coupled to the injection window in the drug delivery system;

FIG. 14 is a bottom view of the control unit being coupled to the injection window in the drug delivery system;

FIG. 15 is an exploded perspective view of the control unit and the injection window in the drug delivery system;

FIG. 16 is a perspective view of the control unit being coupled to an injection window and an adhesive element in the drug delivery system;

FIG. 17 is a side view of the control unit being coupled to the injection window and the adhesive element in the drug delivery system;

FIG. 18 is another side view of the control unit being coupled to the injection window and the adhesive element in the drug delivery system;

FIG. 19 is a front view of the control unit being coupled to the injection window and the adhesive element in the drug delivery system;

FIG. 20 is a back view of the control unit being coupled to the injection window and the adhesive element in the drug delivery system;

FIG. 21 is a top view of the control unit being coupled to the injection window and the adhesive element in the drug delivery system;

FIG. 22 is a bottom view of the control unit being coupled to the injection window and the adhesive element in the drug delivery system;

FIG. 23 is an exploded perspective view of the control unit and the injection window and the adhesive element in the drug delivery system;

FIG. 24 is a perspective view of the injection window in a folded state in the drug delivery system;

FIG. 25 is a side view of the injection window in the folded state in the drug delivery system;

FIG. 26 is another side view of the injection window in the folded state in the drug delivery system;

FIG. 27 is a front view of the injection window in the folded state in the drug delivery system;

FIG. 28 is a back view of the injection window in the folded state in the drug delivery system;

FIG. 29 is a top view of the injection window in the folded state in the drug delivery system;

FIG. 30 is a bottom view of the injection window in the folded state in the drug delivery system;

FIG. 31 is a perspective view of the injection window in an unfolded state in the drug delivery system;

FIG. 32 is a side view of the injection window in the unfolded state in the drug delivery system;

FIG. 33 is another side view of the injection window in the unfolded state in the drug delivery system;

FIG. 34 is a front view of the injection window in the unfolded state in the drug delivery system;

FIG. 35 is a back view of the injection window in the unfolded state in the drug delivery system;

FIG. 36 is a top view of the injection window in the unfolded state in the drug delivery system;

FIG. 37 is a bottom view of the injection window in the unfolded state in the drug delivery system;

FIG. 38 is a top and back perspective view of a charging element in the drug delivery system;

FIG. 39 is a front view of the charging element in the drug delivery system;

FIG. 40 is a back view of the charging element in the drug delivery system;

FIG. 41 is a side view of the charging element in the drug delivery system;

FIG. 42 is another side view of the charging element in the drug delivery system;

FIG. 43 is a top view of the charging element in the drug delivery system;

FIG. 44 is a bottom view of the charging element in the drug delivery system; and,

FIG. 45 is a front perspective view of a charging element in the drug delivery system.

The claimed design is directed to the collective appearance of the control unit, injection window, adhesive element, and charging element of the drug delivery system.

* * * * *


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed